Ignite Creation Date:
2024-05-06 @ 7:06 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02462538
Status:
TERMINATED
Last Update Posted:
2022-03-03
First Post:
2015-05-18
Brief Title:
Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK ALCL
Sponsor:
Organization:
Arbeitsgemeinschaft medikamentoese Tumortherapie